This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A Windsor, Ontario-based company Audacia Bioscience is especially focussed on three patented technologies that deliver consumer and patient insights to the industry to close the knowledge gaps in the supply chain. Virtual ClinicalTrials transcend geographic, mobility and economic barriers.
This article was originally published on Analytical Cannabis and appears here with permission. . In a new survey of German patients with Parkinson’s disease, 8% of patients reported using cannabis products. Of these consumers, over half said the drug had a beneficial clinical effect on their condition.
There are cannabis users, patients, and just everyday fans who may be fans, but don’t make it a big part of their public persona. For these famous medical cannabis patients and supporters, it is something that can improve quality of life and which should be made readily available to anyone in need. 1) Patrick Stewart. It’s tricky.”.
Are you able to answer your patients’ medical marijuana questions? We provide free educational resources, including ‘The Answer of the Day,’ a daily question and answer email that reviews the medical marijuana articles published in the peer-reviewed medical journals. million medical marijuana patients nationwide.
A first-of-its-kind Phase 3 clinicaltrial has found that MDMA-assisted therapy provided meaningful relief from PTSD symptoms in nearly 90 percent of study participants. For this study, researchers recruited 90 patients suffering from severe, chronic PTSD. View original article. Image via.
Patients often struggle with symptoms that range from physical discomfort to cognitive impairment. In this article, we explore how medical marijuana for multiple sclerosis symptoms helps patients, with its diverse cannabinoid components, alleviate MS symptoms, and enhance the quality of life for patients.
I have many patients that want to use cannabis, and they who ask me what product should they get? — and this is probably true in Japan, as well — the time allowed for patient visits has gotten smaller and smaller. I teach many patients breathing exercises, simple breath control methods that I find to be very effective.
There have been more than 7,500 approvals for medicinal cannabis in Australia since legalisation in 2016 – so why don’t we know if it is helping patients? Access to medicinal cannabis for patients was legalised in Australia in 2016, allowing doctors to request permission to prescribe from the Australian government.
9 In a February 2021 article in Nutritional Outlook , Jesse Karagianes, vice president of sales of the CBD natural products company CV Sciences (San Diego, California), was quoted as saying: “[T]he single largest factor which contributed to slow category sales was the deluge of inferior products hitting the market. Accessed July 25, 2021.
a necessary question to address as medical marijuana becomes more accessible. ClinicalTrial Sample Size. The trial was conducted with just 186 participants, which is far too small of a sample size to provide findings generalizable to the larger population. Daily Cannabis Use as a Disqualifier.
However, our drug laws impede research and deny patientsaccess to these highly effective medicines. These disorders include severe depression, anxiety and depression occurring in terminal cancer patients, alcohol and nicotine dependence, and PTSD (post-traumatic stress disorder). Secondly, people report being healed.
While antiretroviral therapy (ART) has transformed HIV/AIDS from a fatal diagnosis to a manageable chronic condition, patients often endure chronic pain, nausea, appetite loss, and psychological distress. Medical marijuana for HIV/AIDS offers a promising complementary treatment for patients.
This is despite a limited number of high-quality clinicaltrials investigating the drug’s efficacy for this condition. Using data from the Therapeutic Goods Administration (TGA) – Australia’s Special Access Scheme B, the researchers found the other two top reasons for prescriptions were pain and sleep disorders.
In this article, you’ll learn why and how medical marijuana is effective for treating OCD. As a result, these patients often experience high levels of stress, anxiety, and depression. Medical Marijuana for a Patient with OCD. This is a great option in Florida for OCD-diagnosed individuals. What Exactly Does OCD Mean?
There’s no doubt that the amount of information that is available about cannabis is at an all-time high – in 2020 alone, over 3,500 scientific articles were published on the topic. These claims influence things like how consumers purchase cannabis or how doctors consult with medical cannabis patients.
This article delves into the science behind medical marijuana, focusing on cannabinoids, the active compounds found in the cannabis plant, and their remarkable therapeutic effects. These compounds may help reduce symptoms and improve the quality of life for patients.
Many patients are turning to cannabis for insomnia relief, seeking its potential to improve sleep quality and duration. In this article, we explore the role of medical marijuana in addressing insomnia, examining its effectiveness, safety considerations, legal aspects, and practical considerations for patients and healthcare providers.
Ultimately, beyond increased access, a big reason that seniors are turning to cannabis is that it helps with a range of health issues. A recently published review article assessing the current state of research noted there were numerous studies supporting significant pain-managing effects. [3] Accessed December 5 2018.
Data collected from MAPS-sponsored Phase 3 clinicaltrials suggests that MDMA-assisted therapy appears promising in the treatment of TBI. The millions of people afflicted with PTSD may soon have access to MDMA therapy, and we believe the millions suffering from TBI may experience similar relief in the future.”.
Bankole Johnson was featured in a March 5 th 2021 Forbes article, “Dr. Johnson, DSc, MD, MPhil, FRCPsych said, “I am pleased to join the Ehave Medical Advisory Board and look forward to working towards bringing psychedelic-assisted therapies to patients experiencing substance use issues. ” About Ehave, Inc. Ehave, Inc.
In a previous article, we explored one potential current opportunity for entrepreneurs interested in psychedelics and mycelium— producing non-psychoactive mushroom supplements. The first path, that of traditional medicine, currently offers patients limited options. 2022 Active FDA ClinicalTrials and State-Regulated Systems.
Patients are unclear on what product to choose and healthcare providers don’t yet have the data to counsel on proper dosage.”. For more background on Radicle ACES methodology and additional insights from collaborators and experts involved in the study, see these Radicle Resources articles. Eric Schudiske, eric@s2spr.com.
This article provides an overview of the current state of legality of common psychedelic substances, and some of the potential therapeutic uses to which psychedelics may be applied. See Usona Institute, A Study of Psilocybin for Major Depressive Disorder (MDD) , ClinicalTrial ID NCT03866174, available at [link].
Chemotherapy remains a cornerstone in cancer treatment, yet its effectiveness often comes at a significant cost to patients. In this article, we explore the effectiveness of medical marijuana in easing chemotherapy side effects, offering insights into its benefits, challenges, and prospects.
The US Food and Drug Administration (FDA) has just approved a new clinicaltrial that will allow therapists to legally use MDMA. For this Phase 1 trial, MAPS will recruit 150 therapists that are currently being trained to conduct MDMA-assisted therapy sessions for PTSD. . View original article.
Oxford-based startup Beckley Psytech in the United Kingdom announced August 15 that it raised $80 million to ramp up clinicaltrials and research using a pharmaceutical formulation of ??5-MeO-DMT We deeply appreciate our value alignment with this team and eagerly anticipate their progress in improving access to these medicines.”.
As reported in the Guardian, Analytical Cannabis emphasises the importance of this for those suffering from conditions such as chronic pain, epilepsy and neurological and psychiatric disorders who have long been seeking access to what they hope is a transformative medicine. Background to the legalisation of medical cannabis in the UK.
The use of THC (Tetrahydrocannabinol) has surged dramatically over the years with an increasing interest in the potential health benefits for medical marijuana patients. Numerous clinicaltrials are underway to further investigate THC’s efficacy, safety, and potential interactions with other medications as well.
For the first time, he was a patient and not a criminal. They presented case studies about patients who have had incredible success from their cannabis treatments. I want to be a part of the change that sees patients become able to access quality cannabis medicines and to change lives. View original article.
However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patientaccess. A total of 117 articles were retrieved for analysis, the majority of which were news stories for a physician audience.
Natalie has worked with private hospitals and clinics in relation to medical malpractice claims, and assisted on cases involving medical devices product liability and clinicaltrials. The Article. But doctors and patients are not only facing administrative or prescribing hurdles – there’s also the cost.
It is hoped that, as a result of these changes, medicinal cannabis products will be more readily and easily accessible to patients through legal channels. amending the objects of the ND Act to incorporate the objective of ensuring medicinal cannabis products are available to Australian patients for therapeutic purposes; and.
This year, we are completing the second Phase 3 clinicaltrial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. MAPS continued to publish Bulletin articles about MDMA research , requests for donations , and discontinuing animal studies.
In this article, we’ll explore how CBD benefits anxiety relief. This variability can pose challenges for medical marijuana patients seeking consistent access to safe and effective CBD products, as well as for businesses aiming to comply with a patchwork of state laws. Image by Suzy Hazelwood on Pexels.
18 articles. Treatment-resistant depression – meaning patients have tried everything possible and did not find relief – is a harrowing condition affecting one in three people with depression – that’s a staggering one hundred million people worldwide for whom current depression treatments just don’t work. Christian Angermayer.
An article where Perry Davidson, Syqe CEO was interviewed offer some insights: “According to Davidson, Syqe Medical has several basic principles. They discovered that the product has to be simple to use because some of the patients are already past their cognitive peaks.
Our audacious mission is to create the new standard of trust and transparency consumers deserve and healthcare providers demand on these widely accessible potential therapies. For more information on the Radicle ACES study, initial results, and methodology, see this Radicle Resources article.
The bill would expand patients’ access to the necessary treatment for more than 50 conditions, including cancer and post-traumatic stress disorder (PTSD), neurological diseases, and chronic pain of neuropathic origin. “; 4) Article 11 shall be worded as follows: ” Article 11. .”;
Article by Jorge P. This article will examine how courts have responded to claims for cannabis, as an element of future care costs, in personal injury cases. Just because another case finds marihuana useful for one patient does not automatically infer that it is medically necessary for another plaintiff. June 6 2019.
Scientific Reports volume 11 , Article number: 23462 ( 2021 ) Cite this article. Since 2017, several clinicaltrials and observational studies have examined the efficacy of MCs in the pediatric population for a few indications, most of them focused on CBD efficacy in Dravet syndrome 28 , 29 , 30. Metrics details.
Medical professionals want more information about medicinal cannabis before they start prescribing it to patients, a new study has found. In nearly every jurisdiction where medicinal cannabis is legal, at least one medical professional is required to sign off for a person to access it. Gardiner , Judith A. Kyle , Lisa M.
In this article, we take a further look into the science behind cannabis and anxiety, examining different strains and their suitability for managing anxiety symptoms. Clinical Research Findings: What Studies Say About Cannabis and Anxiety Numerous studies have explored cannabis’s efficacy in alleviating anxiety symptoms.
Some healthcare professionals are already encouraged by what is known, much of it anecdotal accounts from patients in their practices. The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. Easy access.
Some have restrictive medical marijuana programs that only allow patients with certain conditions to have access to any cannabis medication, including marijuana and hemp. Although scientific research on this has a long way to go, previous studies and clinicaltrials have produced promising results.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content